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This report describes a modification of a procedure developed by others for crosslinking IgG to protein 
A which itself is covalently linked to a gel support. Earlier immunoaffinity columns were described as 
having large antigen-binding capacities and stability under a variety of elution conditions. The present 
data show that columns constructed with earlier techniques were only partially stable to pH 3.0 buffers, 
and, as a result, bound less than 20% of the antigen predicted by theory. Modifying parameters of the 
dimethylpimelimidate crosslinking method led to immunoaffinity columns which did not leak immuno- 
globulin under low pH elution buffer conditions. The new immunoaffinity absorbants, because of the 
increased strength of the couple between the antibody and protein A, were capable of binding antigen at 
over 80% of their theoretical capacity. 
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Introduction 
The development of techniques for the produc- 
tion of antibody coupled immunoaffinity columns 
has made purification of rare proteins both sim- 
pler and more rapid. Conventional methods for 
immobilizing immunoglobulin via cyanogen 
bromide yield very stable column matrices (Axen 
et al., 1967). The random orientation of the cou- 
pled antibody, however, may obstruct the variable 
'antigen binding' regions of the molecule, prevent- 
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ing columns generated by this approach from 
binding their theoretical capacity for antigen. The 
unpredictability of the interaction between 
cyanogen bromide and different types of IgG also 
hampers attempts to generate reliable antibody- 
linked columns. 
To improve the antigen binding capacity of 
IgG crosslinked to column matrices, Gerston and 
Marchalonis (1978) linked antibody to protein 
A-Sepharose. Protein A binds the Fc portion of 
the IgG molecule, leaving the antigen specific sites 
free. This procedure circumvented the problem of 
random antibody-matrix coupling inherent in the 
cyanogen bromide technique. Also, the comple- 
mentary interaction between protein A and the 
constant Fc region of the IgG molecule allowed 
predictable immunoglobulin immobilization, 
avoiding the other major drawback of the conven- 
tional procedure. Schneider et al. (1982) modified 
Gersten and Marchalonis's approach by gener- 
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ating affinity crosslinked matrices which exhibited 
several desirable qualities. First, the immunoaffin- 
ity columns were stable to alkaline elution condi- 
tions and boiling in SDS. Data on acidic elution 
conditions, however, were not available. In ad- 
dition to stability, these immunoaffinity columns 
had larger antigen binding capacities. 
In our hands, Schneider's methodology resulted 
in immunoaffinity columns which were only partly 
stable under pH = 3.0 buffer conditions. In this 
study, we examined several modifications of the 
procedure defined by Schneider's laboratory in an 
effort to improve the stability of the crosslink 
between the protein A-gel matrix and the IgG 
without interfering with the optimal conforma- 
tions of the immunoglobulin. We describe a 
method that allows the preparation of immunoaf- 
finity columns that are both stable to acidic elu- 
tion conditions, pH 3.0, and capable of binding 
50-100% of their theoretical antigen capacities. 
Materials and methods 
Antibody generation and purification 
Antibodies to purified connective tissue activat- 
ing peptide III, (CTAP-III) (Castor et al., 1983, 
1989) and human albumin (Sigma Chemical Co., 
St. Louis, MO) were raised in New Zealand white 
rabbits as described previously (Castor and Cabral, 
1988). These antibodies were subsequently iso- 
lated from rabbit serum using antigen coupled 
affinity columns that were constructed (Castor 
and Cabral, 1988) by immobilizing purified 
CTAP-III and human albumin to activated CH- 
Sepharose 4B (Pharmacia Fine Chemicals, Pisca- 
taway, N J). 
Generation of antibody coupled columns 
(A) Columns generated by cyanogen bromide 
crosslinking. Antibody was covalently cross- 
linked to CNBr-activated Sepharose 4B (Phar- 
macia) using a ligand to dry gel ratio of 25 mg /g  
gel. Initially the gel was swollen in ice cold I mM 
HC1 for 15 rain. The gel was then transferred to a 
sintered glass filter, washed with 200 ml of ice 
cold 1 mM HC1, and again swollen in 0.1 M 
bicarbonate buffer containing 0.5 M NaC1 (cou- 
pling buffer), pH 8.2. Next, the CNBr-activated 
Sepharose 4B was mixed with the antibody 
solubilized in the same bicarbonate-buffered saline 
at a concentration of 1.0 mg/ml .  The ligand was 
then allowed to react with the activated gel for 3.5 
h at room temperature. Subsequently, the reaction 
was stopped by placing the gel onto a sintered 
glass filter and washing with 15 column volumes 
of coupling buffer. The gel was then mixed with 
three column volumes of 0.2 M ethanolamine for 2 
h at room temperature. After stopping the reac- 
tion, the gel-ligand preparation was placed on a 
sintered glass filter and subjected to alternating 
washes (five times with ten column volumes of 
each) with bicarbonate-buffered saline, pH 8.2, 
followed by 0.1 M acetate buffer containing 0.5 M 
NaC1, pH 4.0. It was then poured into a 1.5 × 20 
cm Econo-column (Bio-Rad, Richmond, CA) with 
0.05 M phosphate buffer containing 0.15 M NaC1, 
pH 7.2, and 0.2% sodium azide. 
(B) Schneider crosslinking technique (Schneider 
et al., 1982). Recombinant protein A-agarose 
(Repligen, Cambridge, MA), selected for its high 
IgG binding capacity, was poured with PBS into a 
1.5 x 20 cm Econo-column. Affinity purified anti- 
body in 0.15 M NaC1 was then passed over the 
gel. Unbound antibody was collected and reap- 
plied to the column repeatedly until no further 
IgG would complex with the protein A matrix as 
indicated by UV absorbance at 280 nm. Enough 
gel was used when pouring the column such that 
the IgG preparation saturated only 50% of the 
protein A binding sites. Bound antibody was next 
cross-linked to the protein A matrix by collecting 
the gel on a sintered glass filter and washing it 
with ten column volumes of 0.2 M triethanola- 
mine in 0.1 M borate buffer, pH 8.2. The gel was 
then transferred from the sintered glass filter to a 
solution of 0.2 M triethanolamine in 0.1 M borate 
buffer containing 50 mM dimethylpimelimidate 
prepared 1-3 h ahead of time. The pH of this 
crosslinking solution was readjusted to 8.2 with 
concentrated NaOH. The gel crosslinking solution 
mixture was continuously agitated for 45 min at 
which time the reaction was stopped by first wash- 
ing the gel on a sintered glass filter with 20 
column volumes of 50 mM ethanolamine, pH 8.2, 
and subsequently reacting the gel with 20 column 
volumes of the same 50 mM ethanolamine buffer 
for 5 min. Finally, after terminating the crosslink- 
ing reaction, the gel-antibody complex was poured 
back into a 1.5 x 20 cm Econo-column with PBS 
containing 0.02% sodium azide. 
(C) Experimental modification of Schneider's 
technique: increased reaction time. The Schneider 
procedure described above was repeated except 
that the antibody-protein A complex was reacted 
with previously prepared 50 mM of dimethyl- 
pimelimidate in 0.1 M borate buffer containing 
0.2 M triethanolamine, pH 8.2, for 2 h instead of 
the prescribed 45 min. 
(D) Experimental modification of Schneider's 
technique: increased crosslinker concentration. The 
Schneider procedure was used except that the 
antibody-protein A complex was reacted with 100 
mM of dimethylpimelimidate in 0.1 M borate 
buffer containing 0.2 M triethanolamine, pH 8.2, 
instead of the 50 mM crosslinker concentration. 
The reaction was carried out for 45 min. 
(E) Experimental modification of Schneider's 
technique: repeated crosslinking reactions with 
freshly prepared crosslinker solution. The 
Schneider method was repeated except that the gel 
antibody complex was reacted twice with 50 mM 
crosslinker with each reaction lasting for 45 min. 
In addition, the triethanolamine borate buffer 
solution containing the 50 mM dimethylpimel- 
imidate was prepared immediately before mixing 
it with the gel antibody complex as opposed to 
making up the solution hours ahead of time. 
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Testing the capacity of the columns 
Preparations containing known quantities of 
either human albumin or CTAP-III as determined 
by a UV method (Waddel, 1956) or by radial 
immunodiffusion (RID) (Castor and Cabral, 1988) 
were passed over each of the affinity columns in 
PBS. The column fractions containing the un- 
bound material and the eluted antigen were then 
analyzed for purity using SDS-PAGE (Castor and 
Cabral, 1988) and for protein by the same UV and 
RID methods noted above. 
Results 
The characteristics of columns constructed by 
the Schneider and cyanogen bromide techniques 
are illustrated in Table I. The row headed 'Method 
symbol' denotes the procedure used to generate 
each column; the letters refer to the procedures 
described in the materials and methods section. 
The row headed 'Antigen' specifies the purified 
protein against which the antibodies employed in 
constructing the column were raised. The row 
headed 'Antigen binding capacity' defines the 
maximum amount of specific protein each IgG- 
linked column is capable of binding when exposed 
to a preparation containing saturating amounts of 
antigen. 
TABLE I 
CHARACTERISTICS OF COLUMNS PREPARED WITH CNBr (A) AND PROTEIN A-AGAROSE (B) a 
Method symbol: A B B A B B 
Antigen: Albumin Albumin Albumin C T A P -  III  CTAP-III CTAP-III 
IgG applied 37.0 mg 5.6 mg 7.11 mg 88.7 mg 42.5 mg 41.0 mg 
IgG X-linked 35.5 mg 2.61 mg 4.3 mg 76.1 mg - 
Coupling efficiency 96% 41% 61% 86 % - - 
Antigen binding 
capacity (theory) 31.2 mg 2.30 mg 3.82 mg 9.44 mg - - 
Antigen binding 
capacity (actual) 1.6 mg 0.303 mg 0.40 mg 2.2 mg 0.329 mg 0.290 mg 
Antigen binding 
efficiency 5.13% 13.2% 10.5% 23% 6.2% b 5.7% b 
a B represents method of Schneider et al. (1982). 
b Reflects 'apparent antigen efficiency' and assumes 100% crosslinking of antibody to column; this is shown not to be true in Fig. 1. 
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Fig. 1. A illustrates the UV monitor trace during the initial 
elution (pH 3.0) of a column freshly prepared by the method of 
Schneider et al. (1982). The trace in B reflects column perfor- 
mance where a similar amount  of IgG was immobilized by 
method E. Protein lost by acid elution was shown to be IgG by 
immunodiffusion against IgG antisera; protein measurement  
showed the acid elution loss of IgG was reduced by more than 
80% when immobilized by method E. 
Table I also shows the amount of immuno- 
globulin initially employed to generate each col- 
umn, the amount of the original IgG permanently 
crosslinked to the column matrix, the theoretical 
binding capacity of the immobilized immuno- 
globulin, and the coupling efficiency. The theoreti- 
cal binding capacity of a column is calculated as 
the number of moles of IgG (that which remained 
coupled to the column support), multiplied by 2 
(assuming a divalent antibody), and then multi- 
plied by the molecular weight of the antigen for 
which the antibody is specific. The efficiency of a 
particular column was defined as the column's 
actual binding capacity divided by its theoretical 
binding capacity multiplied by 100. Finally, the 
coupling efficiency is defined as the amount of 
immunoglobulin permanently immobilized to the 
column matrix divided by the initial amount of 
antibody invested in constructing the column and 
converted into a percentage. 
The data in Table I depict the shortcomings of 
columns constructed by both the Schneider and 
cyanogen bromide techniques. With one excep- 
tion, the efficiencies of the columns do not exceed 
15%. The low efficiencies of columns constructed 
by the cyanogen bromide procedure occur despite 
coupling efficiencies of greater than 85%. 
Fig. 1A shows a UV absorbance (280 nm) trace 
which illustrates the elution of antibody cross- 
linked to protein A by the Schneider technique on 
initial exposure to 0.1 M glycine-HC1, pH 3.0. 
Similar traces were seen with modifications C and 
D. Fig. 1B illustrates the reduced quantity of 
immunoglobulin separated from the gel matrix of 
a column constructed by procedure E upon first 
exposure to glycine-HC1, pH 3.0 solution. 
Table II records the characteristics of columns 
constructed by modifications of the Schneider 
procedure. The row headings are identical to those 
found in Table I. The methods noted in Table II 
are those described in the materials and methods 
section. The data in this table suggest that modifi- 
cations of crosslinker concentration and reaction 
time do not influence the stability of the couple 
between the IgG and the protein A. Columns 
constructed using these manipulations display ef- 
ficiencies of less than 17%. Matrices constructed 
TABLE II 
CHARACTERISTICS OF C O L U M N S  PREPARED WITH MODIFICATIONS OF THE D I M E T H Y L P I M E L I M I D A T E  CROSS- 
L I N K I N G  M E T H O D  
Method symbol: C D E E E E 
Antigen: Albumin Albumin Albumin CTAP-III CTAP-III  CTAP-III  
IgG applied 5.6 mg 4.7 mg 3.76 mg 5.33 mg 37.5 mg 33.12 mg 
IgG X-linked 31.8 mg 1.81 mg 3.04 mg 5.33 mg 36.5 mg 32.7 mg 
Coupling efficiency 56.8% 38.5% 80.8% 100% 97.3% 98.7% 
Antigen binding 
capacity (theory) 2.80 mg 1.59 mg 2.68 mg 0.660 mg 4.53 mg 4.05 mg 
Antigen binding 
capacity (actual) 0.424 mg 0.267 mg 1.06 mg 0.690 mg 4.63 mg 3.77 mg 
Antigen binding 
efficiency 15.1% 16.8% 39.6% 104% 102% 93.1% 
by repeating the crosslinking reaction, however, 
do exhibit substantial improvement. The coupling 
efficiencies for this latter group are greater than 
80% and the column efficiencies are, with one 
exception, greater than 80%. 
Discussion 
The rapid decrease in pH of the 50 mM di- 
methylpimelimidate solution during the crosslink- 
ing procedure provided the motivation to modify 
the procedure in two ways. First, the number of 
coupling reactions used to generate each im- 
munoaffinity column was increased, and secondly 
the crosslinker solution was prepared immediately 
prior to matrix construction. Gersten and Marcha= 
lonis (1978) reported that at a low pH, the hydro- 
lysis of the crosslinker is favored over the linking 
reaction. The change in pH after 45 rain suggested 
that all the original dimethylpimelimidate was 
either involved in crosslinking or hydrolyzed so 
that increasing the coupling reaction time would 
not increase the coupling efficiency. This conclu- 
sion is supported by the failure of the increased 
reaction time procedure to improve the efficiency 
of columns generated by this technique. Re- 
peatedly adding fresh dimethylpimelimidate solu- 
tion to the IgG-protein A-agarose provided a 
means to enhance the linkage between the matrix 
and immunoglobulin. 
The relatively low antigen binding capacities of 
antibody-coupled affinity columns generated by 
both the conventional cyanogen bromide cross- 
linking procedure and the novel method devel- 
oped by Gersten and Marchalonis and modified 
by Schneider et al. are denoted in Table I. The 
cyanogen bromide technique, as indicated by the 
high crosslinking efficiencies of columns con- 
structed by this method, allows for stable binding 
of antibody to the gel support. The poor antibody 
binding capacities of the cyanogen bromide gener- 
ated matrices, despite the successful immobiliza- 
tion of nearly all the original antibody, suggests 
the antibody is linked randomly without protec- 
tion of the variable antigen binding regions. 
The reduced antigen binding efficiencies of col- 
umns constructed by Schneider's technique, also 
depicted in Table I, result primarily from insuffi- 
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cient immobilization of the initial antibody to the 
protein A-agarose matrix and not from the ran- 
dom orientation of immunoglobulin coupled to 
the column support. The low crosslinking ef- 
ficiencies (Table I) and the large antibody elution 
peak upon initial exposure of the gel matrix to pH 
3.0 buffer (Fig. 1) substantiate the instability of 
the bridge between the IgG molecule and the 
column support. In addition, Table I indicates 
that antibodies, permanently immobilized by the 
Schneider technique, bind 20% or less of their 
theoretical capacity of specific protein. This may 
indicate either that the immunoglobulins immobi- 
lized on protein A at their Fc region are not 
optimally arranged to bind antigen or that the 
dimethylpimelimidate crosslinker in some way in- 
terferes with the variable regions of the IgG mole- 
cule. Schneider presented data that contradicted 
these two possible sources of protein binding site 
interference; it suggested that, if the immobilized 
IgG could be more tightly secured to the protein 
A-agarose, immunoaffinity columns with antigen 
capacities approaching theory could be generated. 
Their conclusion provided the impetus to modify 
several steps of Schneider's procedure with the 
goal of increasing the antibody-matrix stability 
under acidic elution conditions. 
As Table II exhibits, two modifications tested 
(the increased reaction time treatment and the 
increased crosslinker concentration treatment) did 
not enhance the stability of the antibody-protein 
A complex under low pH conditions relative to 
columns generated by the unmodified Schneider 
procedure. However, performing consecutive 50 
mM dimethylpimelimidate incubations did signifi- 
cantly increase the strength of the couple under 
acidic conditions. Crosslinking efficiencies of 
greater than 80% (Table II), and a small elution 
peak upon first exposure of the gel to an acidic 
buffer (Fig. 1), provide evidence for this improved 
linkage. 
The high antigen binding efficiencies for the 
anti-CTAP-III coupled columns produced by the 
repeated crosslinking technique (Table II) indi- 
cate; as concluded by Schneider, that the antibody 
is stationed on the gel matrix in an orientation 
that allows maximal antigen binding and that the 
dimethylpimelimidate crosslinker does not inter- 
fere with the variable regions of the IgG molecule. 
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This  data,  however,  is inconsis tent  with the behav-  
ior  of  co lumns  cons t ruc ted  by  the unmodi f i ed  
Schneider  me thod  in our  labora tory .  The  dis-  
c repancy  most  l ikely arises f rom a fai lure to 
account  for all the immunog lobu l in  separa ted  f rom 
the agarose suppor t  dur ing  the several washes 
cal led for in the Schneider  procedure .  No t  
account ing  for these losses would  result  in an 
overes t imat ion  of the amoun t  of  crossl inked I g G  
and  thus an overes t imat ion  of  the theoret ical  b ind-  
ing capac i ty  of  the co lumn which would  u l t imate ly  
lead to calculat ions  of poor  ant igen b ind ing  ef- 
ficiencies. 
In  summary ,  mod i fy ing  Schneider ' s  p rocedure  
by  repeat ing  the cross l inking react ion with freshly 
p repa red  50 m M  d ime thy lp ime l imida t e  solut ion 
has a l lowed the genera t ion  of  immunoaf f in i ty  
matr ices  which isolate  mul t imi l l ig ram amount s  of 
pure  ant igen with a single co lumn pass. This capa-  
b i l i ty  has m a d e  the s tudy of  otherwise diff icult  to 
pur i fy  po lypep t ide  growth  factors much  more  
feasible.  This technique,  by  securely fas tening the 
IgG to the Prote in  A-agarose ,  prevents  the was tage  
of an t ibodies  which are diff icult  to p roduce  and 
equal ly  diff icult  to purify.  
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